Prelude Therapeutics Inc (PRLD)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need. Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.
Ask ADVFN Intelligence (AI)
- Encouraging signs of anti-tumor activity including objective responses observed in patients with SMARCA4-mutated non-small cell lung cancer (NSCLC) and esophageal cancer in early PRT3789...
PRT3789, a novel, highly-selective SMARCA2 degrader in patients with advanced solid tumors with a SMARCA4 mutation oral session presentation: September 13, 2024, 4:00 PM CEST (10:00 AM EST...
Interim Phase 1 data for its first-in-class, highly selective IV SMARCA2 degrader, PRT3789, selected for an oral presentation at the European Society for Medical Oncology (ESMO) Congress 2024 in...
Combining a first-in-class, highly selective SMARCA2 degrader with an anti-PD-1 therapy may potentially enhance the anti-tumor activity of either agent because of the complementary nature of the...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -2.3965 | -48.6450827159 | 4.9265 | 5.075 | 2.4 | 915707 | 2.67720317 | CS |
| 4 | -2.9 | -53.4069981584 | 5.43 | 5.945 | 2.4 | 461312 | 3.867894 | CS |
| 12 | -1.18 | -31.8059299191 | 3.71 | 6.8 | 2.4 | 258121 | 4.45503598 | CS |
| 26 | -2.1 | -45.3563714903 | 4.63 | 6.8 | 2.4 | 140663 | 4.40119221 | CS |
| 52 | -0.63 | -19.9367088608 | 3.16 | 6.8 | 1.66 | 145416 | 3.74313089 | CS |
| 156 | -31.88 | -92.6474861959 | 34.41 | 36.95 | 1.66 | 182440 | 9.18216474 | CS |
| 260 | -23.23 | -90.1785714286 | 25.76 | 95.375 | 1.66 | 190362 | 19.38200781 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
